22 results
EPA-1722 – A Double-blind, Placebo-controlled, Randomized Withdrawal Study of lurasidone for the Maintenance of Efficacy in Patients with Schizophrenia
-
- Journal:
- European Psychiatry / Volume 29 / Issue S1 / 2014
- Published online by Cambridge University Press:
- 15 April 2020, p. 1
-
- Article
-
- You have access
- Export citation
EPA-0425 – Effect of Lurasidone on Depressive Symptoms in Patients with Schizophrenia
-
- Journal:
- European Psychiatry / Volume 29 / Issue S1 / 2014
- Published online by Cambridge University Press:
- 15 April 2020, p. 1
-
- Article
-
- You have access
- Export citation
Efficacy of lurasidone across five symptom dimensions of schizophrenia: Pooled analysis of short-term, placebo-controlled studies
-
- Journal:
- European Psychiatry / Volume 30 / Issue 1 / January 2015
- Published online by Cambridge University Press:
- 15 April 2020, pp. 26-31
-
- Article
- Export citation
1046 – Switching To Lurasidone In Patients With Schizophrenia: Tolerability And Effectiveness At 6 Weeks And 6 Months
-
- Journal:
- European Psychiatry / Volume 28 / Issue S1 / 2013
- Published online by Cambridge University Press:
- 15 April 2020, 28-E457
-
- Article
-
- You have access
- Export citation
Long-term Treatment with Lurasidone in Older Adults with Bipolar Depression: Results of a 6 Month Open-label Study
-
- Journal:
- European Psychiatry / Volume 30 / Issue S1 / March 2015
- Published online by Cambridge University Press:
- 15 April 2020, p. 1
-
- Article
-
- You have access
- Export citation
1056 – Comparative Effectiveness Of Long-term Treatment With Atypical Antipsychotics In Patients With Schizophrenia
-
- Journal:
- European Psychiatry / Volume 28 / Issue S1 / 2013
- Published online by Cambridge University Press:
- 15 April 2020, 28-E464
-
- Article
-
- You have access
- Export citation
Remission in Lurasidone-treated Patients with Bipolar I Depression: Post-hoc Analysis of a 6-week, Placebo-controlled Trial Followed by a 6-month Extension
-
- Journal:
- European Psychiatry / Volume 30 / Issue S1 / March 2015
- Published online by Cambridge University Press:
- 15 April 2020, p. 1
-
- Article
-
- You have access
- Export citation
EPA-0321 – Impact of Improved Insight in Schizophrenia: A Double-blind Lurasidone and Quetiapine xr Study
-
- Journal:
- European Psychiatry / Volume 29 / Issue S1 / 2014
- Published online by Cambridge University Press:
- 15 April 2020, p. 1
-
- Article
-
- You have access
- Export citation
EPA-0418 – Long-term Safety and Effectiveness of Lurasidone in Schizophrenia: Results of a 22 Month, Open-label Extension Study
-
- Journal:
- European Psychiatry / Volume 29 / Issue S1 / 2014
- Published online by Cambridge University Press:
- 15 April 2020, p. 1
-
- Article
-
- You have access
- Export citation
1051 – Lurasidone In The Treatment Of Early-stage Schizophrenia: a Post-hoc Analysis Of Three Pooled Acute Treatment Studies
-
- Journal:
- European Psychiatry / Volume 28 / Issue S1 / 2013
- Published online by Cambridge University Press:
- 15 April 2020, 28-E459
-
- Article
-
- You have access
- Export citation
EPA-0423 - Efficacy of Lurasidone in the Treatment of Agitation Associated with Acute Schizophrenia
-
- Journal:
- European Psychiatry / Volume 29 / Issue S1 / 2014
- Published online by Cambridge University Press:
- 15 April 2020, p. 1
-
- Article
-
- You have access
- Export citation
1055 – Effect Of Lurasidone On Weight And Metabolic Parameters: a Comprehensive Analysis Of Short- And Long-term Trials In Schizophrenia
-
- Journal:
- European Psychiatry / Volume 28 / Issue S1 / 2013
- Published online by Cambridge University Press:
- 15 April 2020, 28-E463
-
- Article
-
- You have access
- Export citation
Efficacy and Tolerability of Lurasidone in Older Adults with Bipolar Depression: Analysis of Two 6-week Double-blind, Placebo-controlled Studies
-
- Journal:
- European Psychiatry / Volume 30 / Issue S1 / March 2015
- Published online by Cambridge University Press:
- 15 April 2020, p. 1
-
- Article
-
- You have access
- Export citation
Effect of Lurasidone On Metabolic Parameters in Patients with Bipolar Depression
-
- Journal:
- European Psychiatry / Volume 30 / Issue S1 / March 2015
- Published online by Cambridge University Press:
- 15 April 2020, p. 1
-
- Article
-
- You have access
- Export citation
EPA-0419 – Effect of 12 Months of Treatment on Weight in Subjects with schizophrenia: A Comparison of lurasidone, Risperidone, and Quetiapine XR
-
- Journal:
- European Psychiatry / Volume 29 / Issue S1 / 2014
- Published online by Cambridge University Press:
- 15 April 2020, p. 1
-
- Article
-
- You have access
- Export citation
Optimizing Treatment with Lurasidone in Patients with Schizophrenia: Results of a Randomized, Double-blind, Placebo-controlled Trial
-
- Journal:
- European Psychiatry / Volume 30 / Issue S1 / March 2015
- Published online by Cambridge University Press:
- 15 April 2020, p. 1
-
- Article
-
- You have access
- Export citation
1053 – In Vitro Receptor-binding Profile Of Lurasidone And Other Commonly-used Antipsychotics
-
- Journal:
- European Psychiatry / Volume 28 / Issue S1 / 2013
- Published online by Cambridge University Press:
- 15 April 2020, 28-E461
-
- Article
-
- You have access
- Export citation
Metabolic syndrome in patients with schizophrenia receiving long-term treatment with lurasidone, quetiapine XR, or risperidone
-
- Journal:
- European Psychiatry / Volume 33 / Issue S1 / March 2016
- Published online by Cambridge University Press:
- 23 March 2020, p. S105
-
- Article
-
- You have access
- Export citation
The Efficacy of Lurasidone on PANSS Subscales in Adolescent Patients with Schizophrenia: Results from a 6-week, Double-blind, Placebo-controlled, Multicenter Study
-
- Journal:
- European Psychiatry / Volume 41 / Issue S1 / April 2017
- Published online by Cambridge University Press:
- 23 March 2020, pp. S90-S91
-
- Article
-
- You have access
- Export citation
The Efficacy and Safety of Lurasidone in Adolescent Patients with Schizophrenia: Results of Functional and Quality of Life Measures from a 6-week, Double-blind, Placebo-controlled Study
-
- Journal:
- European Psychiatry / Volume 41 / Issue S1 / April 2017
- Published online by Cambridge University Press:
- 23 March 2020, p. S94
-
- Article
-
- You have access
- Export citation